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Human embryonic stem cells (hESCs) and neural progenitor (NP) cells are excellent models for recapitulating early
neuronal development in vitro, and are key to establishing strategies for the treatment of degenerative disorders.
While much effort had been undertaken to analyze transcriptional and epigenetic differences during the transition of
hESC to NP, very little work has been performed to understand post-transcriptional changes during neuronal
differentiation. Alternative RNA splicing (AS), a major form of post-transcriptional gene regulation, is important in
mammalian development and neuronal function. Human ESC, hESC-derived NP, and human central nervous system
stem cells were compared using Affymetrix exon arrays. We introduced an outlier detection approach, REAP
(Regression-based Exon Array Protocol), to identify 1,737 internal exons that are predicted to undergo AS in NP
compared to hESC. Experimental validation of REAP-predicted AS events indicated a threshold-dependent sensitivity
ranging from 56% to 69%, at a specificity of 77% to 96%. REAP predictions significantly overlapped sets of alternative
events identified using expressed sequence tags and evolutionarily conserved AS events. Our results also reveal that
focusing on differentially expressed genes between hESC and NP will overlook 14% of potential AS genes. In addition,
we found that REAP predictions are enriched in genes encoding serine/threonine kinase and helicase activities. An
example is a REAP-predicted alternative exon in the SLK (serine/threonine kinase 2) gene that is differentially included
in hESC, but skipped in NP as well as in other differentiated tissues. Lastly, comparative sequence analysis revealed
conserved intronic cis-regulatory elements such as the FOX1/2 binding site GCAUG as being proximal to candidate AS
exons, suggesting that FOX1/2 may participate in the regulation of AS in NP and hESC. In summary, a new
methodology for exon array analysis was introduced, leading to new insights into the complexity of AS in human
embryonic stem cells and their transition to neural stem cells.
Citation: Yeo GW, Xu X, Liang TY, Muotri AR, Carson CT, et al. (2007) Alternative splicing events identified in human embryonic stem cells and neural progenitors. PLoS
Comput Biol 3(10): e196. doi:10.1371/journal.pcbi.0030196
Introduction
The human central nervous system is composed of
thousands of neuronal subtypes originating from neural stem
cells (NSCs) that migrate from the developing neural tube.
Such neuronal complexity is generated by a vast repertoire of
molecular, genetic, and epigenetic mechanisms, such as the
active retrotransposition of transposable elements [1], alter-
native promoter usage, alternative RNA splicing (AS),
alternative polyadenylation, RNA editing, post-translational
modiﬁcations, and epigenetic modulation [2]. Understanding
the processes that generate neuronal diversity is key to
gaining insights into neuronal development and paving new
avenues for biomedical research.
Human embryonic stem cells (hESCs) are pluripotent cells
that propagate perpetually in culture as undifferentiated cells
and can be induced to differentiate into a multitude of cell
types both in vitro and in vivo [3]. As hESCs can theoretically
generate all cell types that make up an organism, they serve as
an important model for understanding early human embry-
onic development. In addition, the hESCs are a nearly inﬁnite
source for generating specialized cells such as neurons and
glia for potential therapeutic purposes [4,5]. In recent years,
methods have been introduced to induce hESCs to differ-
entiate into neural progenitors (NPs) [6,7] and neuronal and
glial subtypes [8–12]. The therapeutic interest in under-
standing the molecular basis of pluripotency and differ-
entiation has led to many studies comparing transcriptional
proﬁles in different hESC lines and the study of expression
changes during the differentiation of hESCs to various
lineages [13–17].
NSCs and progenitor cells (NPs) are present throughout
development and persist into adulthood [18–20]. They are
critical for both basic research and developing approaches to
treat neurological disorders, such as Parkinson disease and
amyotrophic lateral sclerosis (ALS), and stroke or head
injuries [21,22]. NSCs and NPCs can be isolated from human
fetal brain tissue [23–26], as well as from several regions of the
adult human brain, such as the cortex, hippocampus, and the
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Several studies have explored expression patterns of NPCs.
For example, Wright et al. identiﬁed ‘‘expressed’’ and ‘‘not
expressed’’ genes in NPCs isolated from the human embry-
onic cortex [24]; Cai et al. used the massively parallel
signature sequencing proﬁling (MPSS) technique to analyze
expression of fetal NPCs in comparison to hESCs and
astrocyte precursors [27]; Maisel et al. used Affymetrix Gene
Chip arrays to compare adult and fetal NPCs propagated in
neurospheres [35]. However, as with hESCs, the focus thus far
has been primarily on transcriptional differences, which
ignores differential RNA processing such as AS, polyadeny-
lation, degradation, or promoter usage.
AS is frequently used to regulate gene expression and to
generate tissue-speciﬁc mRNA and protein isoforms [36–39].
Recent studies using splicing-sensitive microarrays suggested
that up to 75% of human genes undergo AS, where multiple
isoforms are derived from the same genetic loci [40]. This
functional complexity underscores the challenge and impor-
tance of elucidating AS regulation. AS appears to play a
dominant role in regulating neuronal gene expression and
function [41,42]. Examples of splicing regulators that are
enriched and function speciﬁcally in neuronal cells include
the brain-speciﬁc splicing factor Nova [43,44] and neural-
speciﬁc polypyrimidine tract binding protein (nPTB), which
antagonizes its paralogous PTB to regulate exon exclusion in
neuronal cells [45–47]. Finally, an early report estimating that
15% of point mutations disrupt splicing underscores the
importance of splicing in human disease [48]. Indeed, the
disruption of speciﬁc AS events has been implicated in
several human genetic diseases, such as frontotemporal
dementia and parkinsonism, Frasier syndrome, and atypical
cystic ﬁbrosis [49]. While insights into the regulation of AS
have come predominantly from the molecular dissection of
individual genes [36,49], it is becoming clear that molecular
rules can be identiﬁed from large-scale studies of both
constitutive splicing and AS [40].
Most systematic global analyses on AS have focused on
comparisons across differentiated human tissues [50–52].
Only one study, utilizing expressed sequence tag (EST)
collections from stem cells, has attempted to ﬁnd AS
differences between embryonic and hematopoietic stem cells
[53]. However, utilizing ESTs to identify AS has intrinsic
problems, as ESTs tend to be biased for the 39 ends of genes,
and full coverage of the genome by ESTs is severely limited by
sequencing costs. The commercial availability of Affymetrix
exon arrays provides an alternative approach to interrogate
the expression of every known and predicted exon in the
human genome. The Affymetrix GeneChip Human Exon 1.0
ST array contains ;5.4 million features used to interrogate
;1 million exon clusters (collections of overlapping) of
known and predicted exons with more than 1.4 million
probesets, with an average of four probes per exon.
Our goal was to identify and characterize AS events that
distinguish pluripotent hESCs from multipotent NPs, paving
the way for future candidate gene approaches to study the
impact of AS in hESCs and NPs. However, as different hESC
lines were established under different culture conditions
from embryos with unique genetic backgrounds, we expected
that hESCs and their derived NPs might have distinct
epigenetic and molecular signatures [54]. As both common
and cell-line speciﬁc alternatively spliced exons are likely to
be important in regenerative research, in our study two
separate hESC lines were used, with independent protocols
for differentiating the hESCs into NPs positive for Sox1,a n
early neuroectodermal marker. As an endogenously occur-
ring population of NPs, human central nervous system stem
cells grown as neurospheres (hCNS-SCns) were utilized as a
natural benchmark for derived NPs. We developed an
approach called REAP (Regression-based Exon Array Proto-
col), which is based on robust regression that analyzed signal
estimates from Affymetrix exon array data to identify AS
exons. Experimental validation revealed alternative exons
that distinguish hESCs from NPs; some of them also
distinguish hESCs from a variety of differentiated tissues. A
comparison of REAP-predicted alternative events with
independent methods, such as using publicly available tran-
scripts (ESTs and mRNAs) and computational predictions
based on genomic sequence information alone [55], showed a
strong concordance of REAP-identiﬁed AS exons with AS
events identiﬁed from these orthogonal methods. Finally,
using analysis of the sequences ﬂanking REAP-identiﬁed
alternative exons, we were able to discover known and novel
cis-regulatory elements that potentially regulate these AS
events.
Results
Derivation of Neural Progenitors from Embryonic Stem
Cells
NPs were independently derived from two hESC lines, and
RNA extracted from the cell lines was processed and
hybridized onto Affymetrix Human 1.0 ST exon arrays.
Immunohistochemical and reverse-transcriptase polymerase
chain reaction (RT-PCR) analyses demonstrated that the
hESCs expressed pluripotent marker genes, and the derived
NPs expressed multipotent and neurogenic markers similar
to hCNS-SCns. Undifferentiated Cythera (Cyt-ES) and HUES6
(HUES6-ES) hESC lines were maintained in culture as
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Author Summary
Deriving neural progenitors (NP) from human embryonic stem cells
(hESC) is the first step in creating homogeneous populations of cells
that will differentiate into myriad neuronal subtypes necessary to
form a human brain. During alternative RNA splicing (AS), non-
coding sequences (introns) in a pre-mRNA are differentially removed
in different cell types and tissues, and the remaining sequences
(exons) are joined to form multiple forms of mature RNA, playing an
important role in cellular diversity. The authors utilized Affymetrix
exon arrays with probes targeting hundreds of thousands of exons
to study AS comparing human ES to NP. To accomplish this, a novel
computational method, REAP (Regression-based Exon Array Proto-
col), is introduced to analyze the exon array data. The authors
showed that REAP candidates are consistent with other types of
methods for discovering alternative exons. In addition, REAP
candidate alternative exons are enriched in genes encoding
serine/theronine kinases and helicase activities. An example is the
alternative exon in the SLK (serine/threonine kinase 2) gene that is
included in hESC, but excluded in NP as well as in other
differentiated tissues. Finally, by comparing genomic sequences
across multiple mammals, the authors identified dozens of
conserved candidate binding sites that were enriched proximal to
REAP candidate exons.
Alternative Splicing in Human ES and Progenitor Cellspreviously described [12,23,56]. Utilizing speciﬁc antibodies,
we observed that undifferentiated Cyt-ES and HUES6-ES cells
were positive for the pluripotent markers Oct4, SSEA-4, and
Tra-1–80 (unpublished data). NPs were derived from the
hESC cell lines using protocols optimized for each line (see
Materials and Methods). Greater than 90% of derived NP cells
(Cyt-NP from Cyt-ES and HUES6-NP from HUES6-ES) were
positive for Sox1, an early neuroectodermal marker, and
Nestin (Figure 1A), and negative for Oct4 (unpublished data).
As a natural benchmark for the derived NPs, we utilized
hCNS-SCns, which were previously isolated from fresh
human fetal brain tissues using antibodies to cell-surface
markers and ﬂuorescence-activated cell sorting [12,23]. The
hCNS-SCns form neurospheres in culture which are greater
than 90% Nestin and Sox1 positive, and differentiate into both
neurons and glial cells in vitro [12,23]. Immunohistochemical
analysis conﬁrmed that hCNS-SCns were negative for Oct4
(unpublished data) and positive for Sox1 and Nestin (Figure
1A).
Here, known molecular markers were subjected to RT-PCR
measurements, which were compared to gene-level signal
estimates generated from the exon array data. Total RNA was
extracted, and labeled cDNA targets were generated from
three independent preparations of each cell type, namely
Cyt-ES, HUES6-ES, Cyt-NP, HUES6-NP, and hCNS-SCns. To
facilitate downstream analyses, instead of utilizing the meta-
gene sets available from the manufacturers, we generated our
own gene models by clustering alignments of ESTs and
mRNAs to annotated known genes from the University of
California Santa Cruz (UCSC) Genome Browser Database.
After hybridization, scanning, and extraction of signal
estimates for each probeset on the exon arrays, gene-level
estimates were computed based on our gene models using
available normalization and signal estimation software from
Affymetrix. For every gene, a t-statistic and corresponding p-
value were computed representing the relative enrichment of
the expression of the gene in hESC versus NP, such as in Cyt-
ES versus Cyt-NP. After correcting for multiple hypothesis
testing using the Benjamini-Hochberg method, a p-value
cutoff of 0.01 was used to identify enriched genes. Close
inspection of all pairs of hESC-NP comparisons revealed a
generally signiﬁcant overlap from 31% to 85% of the smaller
of two compared sets of enriched genes (see Figure S1). Thus
for the purpose of identifying overall pluripotent and neural
lineage-speciﬁc genes, the collective set of NPs (Cyt-NP,
HUES6-NP, and hCNS-SCns) was compared to the collective
set of hESCs (Cyt-ES and HUES6-ES).
Oct4 and Nanog, which are important in maintaining the
pluripotent state of embryonic stem cells (ESCs), were highly
expressed in hESCs but were signiﬁcantly lower in NPs
(Figure 1B). RT-PCR of Oct4 and Nanog mRNA levels
accurately reﬂected the signal estimates from the array
(Figure 1C). Interestingly, Nestin was not signiﬁcantly higher
in NPs as compared to the hESC from the gene-level
estimates (p-value 0.065), which was further conﬁrmed by
RT-PCR (Figure 1C). Notch was recently identiﬁed to be
important in promoting the neural lineage entry in mouse
ESCs [57] and was shown to regulate stem cell proliferation in
somatic mouse and hESC [58]. Gene-level signal estimates
suggested that Notch was signiﬁcantly higher in hCNS-SCns
relative to hESCs, but levels of Notch were not signiﬁcantly
different in the derived NPs compared to hESCs. Delta/
Notch-like EGF-related receptor (DNER), a neuron-speciﬁc
transmembrane protein, was recently shown to bind to Notch
at cell–cell contacts and activates Notch signaling in vitro [59].
RT-PCR validation of DNER conﬁrmed array-derived signal
estimates, indicating an enrichment of DNER in NPs relative
to hESCs (Figure 1C). Finally, Sox1, a HMG-box protein
related to SRY, was shown to be one of the earliest
transcription factors expressed in cells committed to the
neural fate [60]. Here the gene-level estimates indicated that
Sox1 was expressed signiﬁcantly higher in NPs relative to
hESCs (p-value 0.00013, Figure 1B), a ﬁnding that was
conﬁrmed by RT-PCR (Figure 1C).
From these examples, we concluded that RT-PCR valida-
tion correlated well with gene-level estimates from the exon
array. In addition, the derived NPs had decreased levels of
pluripotent markers Oct4 and Nanog but had levels of Sox1
that were comparable to hCNS-SCns. This ﬁnding conﬁrmed
that the derived NPs were committed to a neural fate and
validated the use of hCNS-SCns as a benchmark for NPs.
Next we asked whether the highest enriched genes in hESCs
relative to NPs reﬂected our existing knowledge in the
literature. Using the above-mentioned groupings of hESCs
(Cyt-ES, HUES6-ES) and NPs (Cyt-NP, HUES6-NP, and hCNS-
SCns), 2,945 genes were enriched in hESCs relative to NPs;
and 552 genes were enriched in the NPs relative to hESCs, at a
p-value signiﬁcance cutoff of 0.01 (correcting for multiple
hypothesis testing using the Benjamini-Hochberg method).
The 15 most enriched genes in hESCs included genes such as
teratocarcinoma-derived growth factor 1 (TDGF1/cripto; p-
value , 10
 12), zinc ﬁnger protein 42 (Zfp42/Rex1; p-value ,
10
 12), Oct4 (p-value , 10
 12), Nanog (p-value , 10
 10), lin-28
homolog (p-value , 10
 10), cadherin 1 preprotein (p-value , 10
 10),
claudin 6 (p-value , 10
 9), ephrin receptor EphA1 (p-value ,
10
 9), and erbB3 (p-value , 10
 9). TDGF1/cripto was ﬁrst shown
to stimulate DNA synthesis and cell proliferation of both
undifferentiated and differentiated embryonic carcinoma
cells [61] and was later shown to be important for
cardiomyocyte formation from mouse ESC [62]. Oct4,
reviewed in [63], and Nanog [64] are crucial for the
pluripotency of hESCs. Recently, knockdown of Zfp42/Rex-1
in mouse ESC caused the cells to differentiate [65]. Our gene-
level exon array analysis conﬁrmed that the hESCs and NPs
were molecularly distinct.
To reveal global functional differences between the
enriched genes in hESCs or NPs, the enriched genes were
subjected to a Gene Ontology (GO, http://www.geneontology.
org) analysis as described previously [55]. Enriched genes in
hESCs were more likely to be in molecular function
categories, such as ‘‘RNA binding’’ (p-value , 10
 12),
‘‘structural constituent of ribosome’’ (p-value , 10
 51),
‘‘exonuclease activity’’ (p-value , 10
 6), ‘‘cytochrome-c
oxidase activity’’ (p-value , 10
 5), and ‘‘ATP binding’’ (p-
value , 10
 6), and in biological processes involved with
‘‘tRNA processing’’ (p-value , 10
 6) and ‘‘protein biosyn-
thesis’’ (p-value , 10
 48), consistent with our knowledge of
hESCs as a rapidly proliferating population of cells (Figure
2A). Similar analysis of the enriched genes in NPs revealed an
overrepresentation in molecular functional categories, such
as ‘‘calcium ion binding’’ (p-value , 10
 8) and ‘‘structural
molecule activity’’ (p-value , 10
 5), and in biological
processes involved with ‘‘neurogenesis’’ (p-value , 10
 38),
‘‘cell adhesion’’ (p-value , 10
 13), ‘‘cell motility’’ (p-value ,
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 4), ‘‘development’’ (p-value , 10
 6), ‘‘neuropeptide signal-
ing pathway’’ (p-value , 10
 4), and ‘‘endocytosis’’ (p-value ,
10
 4) (Figure 2B). Considering that these were the only
categories that were signiﬁcantly enriched out of more than
18,000 GO terms, and that randomly selected sets of similar
numbers of genes did not reveal statistical differences in GO
categories, our results conﬁrmed that the global molecular
proﬁles derived from exon array analysis were consistent with
known differences between hESCs and NPs.
To summarize, ﬁrstly immunohistochemical and RT-PCR
evidence validated that the cells exhibited expected charac-
teristics; secondly, stage-speciﬁc marker gene differences by
RT-PCR were reﬂected accurately by gene-level estimates
from the exon arrays; thirdly, the hESC-enriched genes were
coherent with known genes that controlled pluripotency and
self-renewal; and lastly, the global functional proﬁles exem-
pliﬁed expected biological differences between hESC and NP
cells.
Description of the Regression-Based Exon Array Protocol
Convinced that the signal estimates from the exon arrays
reﬂected expected molecular and biological differences
between hESCs and NPs, we sought to identify AS events.
Figure 1. Molecular Characterization of Human Embryonic Stem Cell Lines and Neuronal Progenitors
(A) Immunohistochemical analysis of markers in NPs derived from the hESC lines (Cyt-NP from Cyt-ES; and HUES6-NP from HUES6-ES) and in hCNS-SCns.
Cyt-NP, HUES6-NP, and hCNS-SCns cells were Nestin and Sox1 positive. Nuclei stained positive for Dapi. White horizontal bar indicated 15 lm.
(B) Gene-level signal estimates of marker genes (GAPDH, Oct4, Nanog, Nestin, Notch1, DNER, and Sox1) from Affymetrix exon array analysis. Vertical bars
indicated average log2 normalized signal estimates, and error bars represented standard deviations from three independent replicate experiments per
cell type.
(C) RT-PCR of marker genes (GAPDH, Oct4, Nanog, Nestin, Notch1, DNER, and Sox1).
doi:10.1371/journal.pcbi.0030196.g001
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Alternative Splicing in Human ES and Progenitor CellsWe compared Cyt-ES to hCNS-SCns to illustrate our
approach. First we normalized the data and generated signal
estimates with Robust Multichip Analysis (RMA) and esti-
mated the probability that each probeset was detected above
background (DABG) using publicly available Affymetrix
Power Tools (APT). We analyzed probesets that (i) comprised
three or more individual probes; (ii) were localized within the
exons of our gene models with evidence from at least three
sources (mRNA, EST, or full-length cDNA); and (iii) were
detected above background in at least one of the cell lines. In
total, 17,430 gene models were represented by probesets that
satisﬁed these criteria.
Next we asked whether the probeset expression within each
gene model was positively correlated for any two cell lines. To
do this we calculated the Pearson correlation coefﬁcient
between the vectors of median signal estimates across
replicates in Cyt-ES versus hCNS-SCns. The vast majority of
genes (.80%) was found to have probeset-level Pearson
correlation coefﬁcients of greater than 0.8 (Figure 3A). Next
we randomly permuted the association between the median
signal estimates and the probesets for each gene in hESCs (or
hCNS-SCns) and observed that the distribution of Pearson
correlation coefﬁcients for the permuted sets was centered at
zero, as expected (Figure 3A). This indicated that the signal
estimates for probesets between hESCs and hCNS-SCns were
highly correlated and suggested that a scatter plot of probeset
signal estimates between hESCs and hCNS-SCns would reveal
a linear relationship for the majority of genes. We hypothe-
sized that a linear regression to determine if some probesets
behaved unexpectedly in one cell type compared to the other
might be a reasonable approach to identify AS exons.
Here, a possible representation of the data was explored. If
we had N replicates in one condition and M replicates in the
other, we could consider N*M points if we analyzed every
possible pairing. For instance, three replicate signal estimates
for every probeset per cell line, such as signal estimates a, b,
and c in hESCs and d, e, and f in hCNS-SCns, would translate
to pairing every signal (d,a), (d,b), (d,c) ...(f,a), (f,b), (f,c) for
linear regression (Figure 3B). Instead, pairing the signal
estimates of all replicates in one condition to the median of
Figure 2. Gene Ontology Analysis
Differential gene expression of hESCs (Cyt-ES and HUES6-ES) and NPs (Cyt-NP, HUES6-NP, and hCNS-SCns) was computed from gene-level signal
estimates. Statistical significance for differential gene expression was determined by using t-statistics with Benjamini-Hochberg correction for false
discovery rate (p , 0.01). Gene Ontology ‘‘molecular function,’’ ‘‘cellular component,’’ and ‘‘biological process’’ categories, which differed significantly
(p , 0.05) in the representation between significantly enriched genes (black bars) and all other genes (white bars), were shown. Statistical significance
for GO analysis was assessed by using v
2 statistics with Bonferroni correction for multiple hypothesis testing. GO categories are ordered from top to
bottom in order of decreasingly significant bias toward enriched genes.
(A) GO analysis of enriched genes in hESCs.
(B) GO analysis of enriched genes in NPs.
doi:10.1371/journal.pcbi.0030196.g002
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Alternative Splicing in Human ES and Progenitor Cellsthe other would only require N þ M   1 points and would
capture the variation of the signal estimates of each probeset.
For example, we considered (d,b), (e,a), (e,b), (e,c), and (f,b)
points where b and d were the median intensities for the
replicates in Cyt-ES and hCNS-SCns, respectively (Figure 3B).
A scatter plot of all probesets of the EHBP1 (EH domain
binding protein, RefSeq identiﬁer NM_015252) is shown in
Figure 3C in the format described. Each probeset was
represented by 5 points of log-transformed (base 2) values;
and each point on the scatter plot reﬂected the extent of
inclusion of an exon in hESCs and in hCNS-SCns (Figure 3C).
A classical linear regression model could be proposed to ﬁt
the response variable yij, the log2 expression of probeset i in
cell-type j (for example, j is Cyt-ESC) to explanatory variables
xik, and the log2 expression of probeset i in cell type k (for
example, k is hCNS-SCns). However, classical linear regres-
sion by least-squares estimation is biased because the least
squares predictions are strongly inﬂuenced by the outliers,
leading to completely incorrect regression line estimates,
masking of the outliers, and incorrect predictions of outliers.
Therefore, we applied M-estimation robust regression to
estimate the line, which is less sensitive to outliers. Fitting was
performed using an iterated, re-weighted least squares
analysis. Our assumption was that most of the points were
‘‘correct,’’ i.e., that most of the exons were constitutively
spliced. Thus, robust regression would ﬁnd the line that was
least dependent on outliers, which would be potential AS
exons. This assumption was substantiated by our observation
that, using publicly available ESTs and mRNAs, a minority of
human exons (7%) have evidence for exon-skipping, the most
Figure 3. Description of the REAP Algorithm Comparing Exon Array Signal Estimates from hCNS-SCns and Cyt-ES
(A) Histogram of Pearson correlation coefficients computed from median signal estimates for probesets between Cyt-ES versus hCNS-SCns for genes
(blue bars). Genes were required to have more than five probesets localized within the exons in the gene. Red bars represented Pearson correlation
coefficients computed from exons with shuffled signal estimates.
(B) Each probeset contained probeset-level estimates from three replicates each, (a, b, c) in Cyt-ES and (d, e, f) in hCNS-SCns. The five points
summarizing the log2 probeset-level estimates are indicated by black filled circles.
(C) Each probeset was summarized by five points. Scatter plots of signal estimates for probesets that were present in at least one cell type (Cyt-ES or
hCNS-SCns) for the EHBP1 gene. Probesets were considered present if the DABG p-value was ,0.05 for all three replicates in the cell type. A regression
line derived from robust linear regression with MM estimation is indicated. Points above the line represent probesets within exons that were enrichedi n
Cyt-ES and points below represent exons that were enriched in hCNS-SCns. Points close to the regression line are not significantly different in Cyt-ES
versus hCNS-SCns. Boxed points represented the five-point summary of a probeset that was significantly enriched in Cyt-ES but was skipped in hCNS-
SCns.
(D) Histogram of studentized residuals for points from the scatter plot in (C) in EHBP1.
(E) The histogram of studentized residuals for all points for all analyzed probesets (100 bins).
(F) The scatter plot of studentized residuals generated from comparing Cyt-ES versus hCNS-SCns and hCNS-SCns versus Cyt-ES of 5,000 randomly
chosen probesets.
doi:10.1371/journal.pcbi.0030196.g003
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Alternative Splicing in Human ES and Progenitor Cellscommon form of AS. Using robust regression, the regression
line for Cyt-ESC versus hCNS-SCns in the EHBP1 gene is
illustrated in Figure 3C. The boxed points belonged to a
probeset that was enriched in hESCs but depleted in hCNS-
SCns, which was suspected to be due to AS. The difference
between the actual and regression-based predicted value,
normalized by the estimate of its standard deviation, is called
the studentized residuals. Studentized residuals were com-
puted for all probeset pairs in EHBP1, and the histogram
depicting their distribution is illustrated in Figure 3D. As
expected, the mean of the distribution was close to zero, and
the distribution was approximated by a t-distribution with n-
p-1 degrees of freedom, where n was the number of points on
the scatter plot, and the number of parameters p was 2. The
boxed points had studentized residuals of 1.829, 3.104, 2.634,
3.012, and 2.125 with p-values of 0.034, 0.00119, 0.00477,
0.00158, and 0.01780, respectively, computed based on the t-
distribution (Figure 3C). At a stringent p-value cutoff of 0.01,
four of the ﬁve studentized residuals were designated as
signiﬁcant ‘‘outliers,’’ indicating that the probeset was
‘‘unusual.’’ RT-PCR conﬁrmed that the exon, represented
by the probeset, was indeed differentially included in hESCs
and skipped in hCNS-SCns (Figure 7B). Applying this
approach to all gene models revealed that, as expected, the
majority of studentized residuals are centered at zero (Figure
3E). Thus far in the example, our analysis was based on
regression of hESCs (y-axis) versus hCNS-SCns (x-axis) (Figure
3B–3D). However, robust regression as described was not
symmetrical, i.e., parameter estimation of y as a function of x
was not the same as that of x as a function of y. The negative
slope revealed that probesets enriched in hESCs versus hCNS-
SCns (positive valued), were expectedly depleted when hCNS-
SCns was compared to hESCs (negative valued; Figure 3F). As
our method for predicting candidate alternative exons was
based on identiﬁcation of outliers using robust regression, we
named the method REAP.
Identification and Removal of False Positives
In the process of experimentally validating our predictions,
we encountered three main sources of false positives (FP)
from robust regression. First, we identiﬁed genes with
probeset signal estimates that were poorly correlated and
were not amenable to our method. As an example, the
median probeset signal estimates in hESCs and hCNS-SCns of
the FIP1L1 gene (gene identiﬁers BC011543, AL136910) had a
Pearson correlation coefﬁcient of 0.38, and the distribution
of points was not amenable to robust regression (Figure 4A).
To avoid inappropriate application of REAP and generating
false predictions, we empirically determined that a gene had
to have a Pearson correlation coefﬁcient cutoff of 0.6 before
being amenable to REAP analysis. Next, we managed two
additional sources of FPs, namely ‘‘high-leverage’’ and ‘‘high-
inﬂuence’’ points, which we were able to identify by
computing the following metrics. For every point, we
computed (i) the studentized residual (as described above),
(ii) the inﬂuence, and (iii) the leverage (see Materials and
Methods for more details). Leverage assessed how far away a
value of the independent variable was from the mean value;
the farther away the observation the more leverage it had.
The inﬂuence of a point was related to its covariance ratio: a
covariance ratio larger (or smaller) than 1 implied that the
point was closer (or farther) than was typical to the regression
line, so removing it would hurt (or help) the accuracy of the
line and would increase (or decrease) the error term variance.
Inﬂuence was computed as the absolute difference between
the covariance ratio and unity. To illustrate further, a point
was classiﬁed as an ‘‘outlier’’ if it had a large studentized
residual (p , 0.01) and low leverage (boxed point ‘‘a’’); as a
‘‘high-leverage’’ point if it had a low studentized residual and
high leverage (boxed point ‘‘b’’); and as a ‘‘high-inﬂuence’’
point if it had a high studentized residual, high leverage, and
high inﬂuence (boxed point ‘‘c’’; Figure 4B). Points that
resembled boxed point ‘‘a’’ were designated as potential AS
events. For example, four of the ﬁve boxed points in Figure
3C were ‘‘outliers,’’ and RT-PCR validation indicated that the
exon represented by the probeset was indeed skipped in
hCNS-SCns (EHBP1, Figure 7B). Points that were ‘‘high-
leverage,’’ such as the ﬁve points in the CLCN2 gene, were
experimentally veriﬁed to be a FP (Figure 4C; unpublished
data). Points that were ‘‘high-inﬂuence,’’ such as the four of
ﬁve boxed points in the ABCA3 gene were also experimentally
veriﬁed to be a FP (Figure 4D; unpublished data). In
conclusion, in order to reduce the FP rate, all points were
evaluated according to the metrics described, and points that
were signiﬁcant ‘‘outliers’’ were considered putative AS
events.
Global Identification and Characterization of REAP[þ]
Exons
REAP was applied to identify AS events in NPs compared
to hESCs: Cyt-NP versus Cyt-ES; HUES6-NP versus HUES6-
ES; hCNS-SCns versus Cyt-ES, and hCNS-SCns versus HUES6-
ES. After removing potential FPs, 11,348 genes containing
158,657 probesets were scored by REAP.
As described above, for each pair of cell lines compared,
each probset was represented by ﬁve points, where each point
was deﬁned a signiﬁcant outlier if it had a high residual (p ,
0.01), low inﬂuence, and high leverage. Points per probeset
should be correlated; in other words, if one point was a
signiﬁcant outlier, the other points were expected to be
outliers as well. To ensure that this was the case, we counted
the number of probesets with N signiﬁcant outliers, where N
was varied from 0 to 5. Next, the identity of the probesets and
points derived from them were exchanged with other
probesets, keeping constant the total number of points that
were considered signiﬁcant outliers. At N ¼ 0, we observed
approximately equal numbers of probesets in the actual
versus shufﬂed controls. In contrast, we observed that there
were 1.5 times more probesets with N ¼ 2 signiﬁcant outliers
relative to shufﬂed controls; 12–31 times more probesets with
N ¼ 3; and 17–612 times more probesets that had N ¼ 4
signiﬁcant outliers (Figure 5A; see Table S1). For example, in
hCNS-SCns compared to Cyt-ES, approximately 0.39% (490
of 124,604) of probesets had three signiﬁcant outliers and
0.25% (308 probesets) had four signiﬁcant outliers, relative to
0.02% and 0% of shufﬂed controls, respectively.
Next we asked whether the overlap between related
comparisons was higher than expected. Comparing the
signiﬁcant probesets between hCNS-SCns versus Cyt-ES and
hCNS-SCns versus HUES6-ES revealed 672 signiﬁcant probe-
sets (N   2), whereas if we shufﬂed the associations between
probeset identity and signiﬁcant outliers, only four signiﬁ-
cant probesets (N   2) were identiﬁed—a 168-fold enrich-
ment (Figure 5B, Table S1). A total of 236 signiﬁcant
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hESCs (Cyt-NP versus Cyt-ES and HUES6-NP versus HUES6-
ES), relative to seven signiﬁcant probesets (34-fold enrich-
ment).
At a cutoff of two signiﬁcant outliers, 1,737 probesets
contained in internal exons were deﬁned as positive REAP
predictions (hereafter called REAP[þ]) exons—candidate AS
events that distinguished NP from hESC. Surprisingly, we
observed that the majority of REAP[þ] exons were speciﬁc to
the pair of hESC and NP that was compared, likely reﬂecting
differences in genetic origins and/or culturing and differ-
entiation conditions of the cell lines: 614 REAP[þ] events
were unique to hCNS-SCns versus HUE6-ES; 220 were unique
to hCNS-SCns versus Cyt-ES; 439 were unique to HUES6-NP
versus HUES6-ES; and 250 were unique to Cyt-NP versus Cyt-
ES. The shared events between pairs of comparisons made up
a minority of the total number identiﬁed: 102 REAP[þ] events
were found to be in common between hCNS-SCns versus Cyt-
ES and hCNS-SCns versus HUES6-ES; 48 between hCNS-SCns
versus HUES6-ES and HUES6-NP versus HUES6-ES; and only
17 between hCNS-SCns versus Cyt-ES and Cyt-NP versus Cyt-
ES (Table S2).
Comparison of REAP to EST-Based Method and ACEScan
Traditionally, AS exons were discovered by using EST
alignments to genomic loci, and also more recently by
computational algorithms that used sequence information
extracted from multiple genomes. Here, we compared REAP
predictions to both approaches. In the ﬁrst comparison,
publicly available ESTs and mRNA transcripts were aligned to
the human genome sequence. 13,934 exons with evidence for
exon-skipping and/or inclusion (EST-SE for EST-veriﬁed
skipped exons) were generated, comprising ;7% of all
internal exons. First we analyzed Cyt-ES versus hCNS-SCns.
If we required that none of the points per probeset (exon) was
signiﬁcant, 6% (4,402 of 71,731) of exons (after probeset
mapping) had evidence for EST-SE (Figure 6A). Shufﬂing the
mapping between these probesets and exons resulted in 8%
(5,777 of 71,731) of exons with evidence for EST-SE (Figure
6A). These percentages were not signiﬁcantly different from
the 7% of exons with EST evidence for AS observed from
using all exons. By raising the requirement that probesets had
to contain at least one signiﬁcant point to ﬁve signiﬁcant
points, the percentage of EST-SE increased dramatically from
11% (531 of 4,898 exons) to 26% (33 of 126). In comparison,
the shufﬂed probesets at the same requirements remained at
;8%, rising slightly to 11% at ﬁve points, due to small sample
sizes. Similar trends were observed with hCNS-SCns versus
HUES6-ES and the derived NPs versus hESCs (Figure 6A).
Therefore, we concluded that REAP[þ] exons were enriched
for AS events independently identiﬁed by a transcript-based
approach.
Next, we compared REAP predictions to a computational
approach of identifying exons with AS conserved in human
and mouse, ACEScan [55]. ACEScan receives as input
orthologous human–mouse exon pairs and ﬂanking intronic
regions and computes sequence features and integrates the
features into a machine-learning algorithm to assign a real-
valued score to the exon. A positive score indicated a higher
likelihood of being AS in both human and mouse. ACEScan
was updated in the following ways. Firstly, instead of relying
on orthology information by Ensembl, and then aligning
ﬂanking introns in ‘‘orthologous’’ exons, conserved exonic
and intronic regions in human and mouse from genome-wide
multiple alignments were extracted. Secondly, whereas in our
previous analysis exons from the longest transcript in
Ensembl were utilized, now we collapsed all the transcripts
available at the UCSC genome browser and analyzed all exons
in the entire gene loci. ACEScan was utilized to assign
ACEScan scores to all ;162,000 internal exons in our genes.
Exons annotated as ﬁrst or last exons in Refseq mRNAs were
excluded from our analysis, resulting in 4,487 positive-scoring
exons, 2-fold more exons than originally published.
Here we repeated our analysis with exons with positive
ACEScan scores (ACE[þ]) instead of EST-SEs. If we required
that none of the points per probeset (exon) was signiﬁcant,
2% (1,645 of 71,731) of exons (after probeset mapping) were
ACE[þ] (Figure 6B). Shufﬂing the mapping between these
probesets and exons resulted in 3% (2,044 of 71,731) of exons
being ACE[þ] (Figure 6B). These percentages were not
signiﬁcantly different from the 2.7% observed from all exons
(4,487 of the 162,000 exons that were scored by ACEScan). By
raising the requirement that probesets had to contain ﬁve
signiﬁcant points, the percentage of ACE[þ] exons increased
from 4% to 11%. However, the sample sizes were small. In
comparison, the shufﬂed probesets at the same requirements
remained at ;4%. Similar overall trends were observed with
hCNS-SCns versus HUES6-ES and the derived NPs versus
hESCs (Figure 6B). In total, 7.5% (131 of 1,737) of REAP [þ]
Figure 4. Sources of False Positives
(A) Scatter plot of points for the FIP1L1 gene and the line representing
the robust regression estimate.
(B) Boxed point ‘‘a’’ represents a significant ‘‘outlier’’ (with a significantly
different studentized residual and low leverage). Boxed point ‘‘b’’
represents a ‘‘high leverage’’ point (low studentized residual and a high
leverage). Boxed point ‘‘c’’ represents a ‘‘high influence’’ point (high
studentized residual, high leverage, and high influence).
(C) Scatter plot of points for the CLCN2 gene. Boxed points represent
‘‘high leverage’’ points.
(D) Scatter plot of points for the ABCA3 gene. Boxed points represent
‘‘high influence’’ points.
doi:10.1371/journal.pcbi.0030196.g004
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(2,328 of 97,437) of REAP[ ] exons. This result suggested that
a small but signiﬁcantly enriched fraction of AS events in
hESCs versus NPs was likely to be evolutionarily conserved in
human and mouse. In conclusion, our results suggested that
REAP predictions were congruent with predictions from two
independent, orthogonal methods.
Experimental Validation of Alternative Exons
The sensitivity and speciﬁcity of REAP in the identiﬁcation
of REAP[þ] exons was tested by RT-PCR. To validate REAP[þ]
alternative exons, RT-PCR primers were designed in the
ﬂanking exons to amplify both isoforms. To be a positively
validated candidate, the PCR products on a gel had to satisfy
all of the following criteria: (i) at least one isoform with the
expected size must be visible in each cell type; (ii) the relative
abundance of the two isoforms must be altered between two
cell types and the direction of change have to be consistent
with the REAP studentized residuals: in our study positive
residuals implied inclusion in hESCs and skipping in NPs, and
negative residuals implied inclusion in NP and skipping in
hESCs; and (iii) the results were replicable in at least two
experiments.
For simplicity of design, we tested candidates predicted
from Cyt-ES versus hCNS-SCns. Fifteen REAP[þ] exons with
at least two signiﬁcant outliers (out of ﬁve) were randomly
chosen as predicted alternative events and thirty-ﬁve exons
with less than two signiﬁcant outliers were randomly chosen
as constitutive events (Table S3). Nine of the ﬁfteen exons
Figure 5. Correlation between ‘‘Outliers’’
(A) The number of probesets with N significant ‘‘outliers’’ was
determined for hCNS-SCns versus Cyt-ES, hCNS-SCns versus HUES6-ES,
Cyt-NPs versus Cyt-ES, and HUES6-NPs versus HUES6-ES (N¼0, 1, 2, 3, 4,
5). For comparison, points to probeset relationships were randomly
permuted, retaining the same number of ‘‘outliers.’’ Vertical bars
represent the ratio between the number of actual points and the
randomly permutated sets.
(B) Similar to (A), except points were counted as ‘‘outliers’’ only if they
were ‘‘outliers’’ in both hCNS-SCns versus Cyt-ES and hCNS-SCns versus
HUES6-ES (combined hCNS-SCns versus hESC; blue bars); in both HUES6-
NP versus HUES6-ES and Cyt-NP versus Cyt-ES (combined derived NP
versus hESC; red bars); and in all four comparisons (combined NP versus
hESC; yellow bar).
doi:10.1371/journal.pcbi.0030196.g005
Figure 6. Comparison of REAP Predictions for hCNS-SCns versus Cyt-hES,
hCNS-SCns versus HUES6-ES, Cyt-NP versus Cyt-ES, and HUES6-NPs
versus HUES6-ES with Alternative Exons Identified by an EST-Based
Method and ACEScan
(A) Black-filled squares represented the fraction of exons containing
probesets with N significant points that had EST evidence for exon
inclusion or exclusion (N ¼ 0, 1, 2, 3, 4 and 5). White-filled triangles
represented similarly computed fractions with permuted probeset to
exon mappings.
(B) Black-filled squares represented the fraction of exons containing
probesets with N significant points that had ACEScan positive scores,
indicative of evolutionarily conserved alternative exons. White-filled
triangles represented similarly computed fractions with permuted
probeset to exon mappings.
doi:10.1371/journal.pcbi.0030196.g006
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sensitivity and speciﬁcity of the algorithm at the cutoff of two
is 69% and 77%. Increasing the cutoff to three increased the
speciﬁcity to 85%, with a slight decrease in sensitivity to 67%
(Figure 7A). The patterns of AS in hESCs were similar in both
Cyt-ES and HUES6-ES for all AS events validated, but the NPs
(Cyt-NP, HUES6-NP, and hCNS-SCns) had more varied AS.
The pattern of AS in the REAP[þ] exons in the SLK (serine/
threonine kinase 2) and POT1 (protection of telomeres 1)
genes showed remarkable agreement within derived NPs and
hCNS-SCns (Figure 7B). The AS exon in SLK was observed to
be included in hESCs and completely excluded in NPs; the AS
exon in the POT1 gene was included more in hESCs and a
smaller isoform persisted in NPs. The AS patterns of the
other veriﬁed REAP[þ] exons were consistently similar in
hESCs but were more varied in the NP. Interestingly, the
patterns of AS in the derived NPs (Cyt-NP and HUES6-NP)
were not always identical to those of hCNS-SCns. For
example, the AS exon in the EHBP1 (EH domain binding
protein 1) gene was included in hESCs but skipped in hCNS-
SCns, and both isoforms were present in the derived NPs
(Figure 7B). As another example, the AS exon in the SORBS1
(sorbin and SH3 domain containing 1) gene was skipped in
hESCs and included in hCNS-SCns, but exhibited an
intermediate pattern in the derived NPs. However, in some
cases, the AS patterns in the derived NPs were different from
both hESCs and hCNS-SCns (such as in the AS exon in
UNC84A, SIRT1, and MLLT10).
First, given three independent samples each from two
conditions, we concluded that REAP was able to identify AS
events with high speciﬁcity but with moderate sensitivity.
Second, AS events in hESCs were more similar, whereas the
AS events in derived NPs were consistent with or intermedi-
ate to the benchmark hCNS-SCns, likely reﬂecting differences
in the cell lines and/or differentiation protocols. In addition,
we tested the AS patterns of REAP[þ] exons from EHBP1,
Figure 7. RT-PCR Validation of REAP-Predicted Alternative Exons
(A) Probesets (exons) were considered REAP[þ] candidates if they contained at least N¼2 (white bars), 3 (gray bars), or 4 (black bars) significant outliers.
True positive (TP), true negative (TN), false positive (FP), and false negative (FN) rates were calculated from RT-PCR-validated REAP[þ] exons at the
different cutoffs (N ¼ 2, 3, 4).
(B) Nine RT-PCR validated REAP[þ] AS events in hESCs (Cyt-ES and HUES6-ES), derived NPs (Cyt-NP and HUES6-NP), and hCNS-SCns. Arrows indicate the
larger (exon-included) isoforms and smaller (exon-skipped) isoforms.
(C) RT-PCR of REAP[þ] alternative exons from EHBP1, SLK, and RAI14 across a panel of human tissues. Arrows indicate the larger (exon-included) isoforms
and smaller (exon-skipped) isoforms.
doi:10.1371/journal.pcbi.0030196.g007
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(Figure 7C). The REAP[þ] alternative exon in the RAI14
(retinoic acid induced 14) gene was observed to have the same
AS pattern in NPs as in frontal and temporal cortex and in
several other, non-brain adult tissues, such as heart and
spleen. The AS pattern of the REAP[þ] exon in the SLK gene
in NPs was similar to most differentiated tissues; however, the
relatively strong inclusion of the exon in hESCs was unique.
Even in esophagus, kidney, liver, and prostate, both isoforms
were present. The relative ratio of the exon-included to exon-
skipped isoforms in SLK likely represents an ESC-speciﬁc AS
signature. The alternative exon in the EHBP1 gene was
unusual. The exon was included in hESCs but also in frontal
cortex and temporal cortex, a ﬁnding that was unexpected
given the exclusion of the exon in hCNS-SCns (Figure 7C).
The AS pattern in hCNS-SCns may represent a transient,
early neuronal molecular change.
Functional and Expression Characteristics of REAP[þ]
Genes
In total, 1,500 genes were identiﬁed that contained 1,737
REAP[þ] exons, 68% of which lacked prior transcript (EST/
cDNA) evidence for AS. To determine whether genes that
contained REAP[þ] exons, which we refer to as REAP[þ] genes,
are biased toward particular biological activities, REAP[þ]
genes were compared to a set of REAP analyzed genes not
found to have REAP[þ] exons (REAP[ ] genes). A Gene
Ontology analysis revealed that REAP[þ] genes are enriched
for GO molecular function categories ‘‘ATP binding,’’ ‘‘heli-
case activity,’’ ‘‘protein serine/theronine kinase activity,’’
‘‘small GTPase regulatory/interacting protein activity,’’ and
‘‘thyroid hormone receptor binding’’ (Table 1). In terms of
GO biological process categories, REAP[þ] genes were more
frequently involved in ‘‘ubiquitin cycle.’’ Similar results were
obtained when we compared REAP[þ] genes to all human
genes that did not contain REAP[þ] exons (Table 1) [55].
Next we asked if REAP[þ] genes are differentially expressed
in hESCs compared to NPs and vice versa. For this analysis,
the t-statistics computed above measuring the enrichment of
a gene in hESCs relative to NPs was utilized for only REAP-
analyzed genes. At a deﬁned absolute-valued cutoff, genes
were divided into three categories: ‘‘enriched in hESCs,’’
‘‘enriched in NP,’’ or ‘‘unchanged’’ (Figure 8A). Increasing the
t-statistic cutoff from one to ﬁve, the fraction of REAP[þ]
genes relative to REAP-analyzed genes remained constant in
the ‘‘unchanged’’ categories (Figure 8B). However, the
fraction of REAP[þ] exons decreased signiﬁcantly in ‘‘en-
riched in hESCs’’ and ‘‘enriched in NPs’’ categories. If we
increased the cutoffs on genes that were randomly assigned as
REAP[þ] and REAP[ ], controlling for the same number of
genes in each category, we observed that the fraction of
REAP[þ] exons remained unchanged for all three categories
(Figure 8C). To illustrate, at a cutoff of ﬁve, 10% (29 of 267) of
enriched NP genes were REAP[þ] genes and 8.8% (102 of
1,162) of enriched hESC genes were REAP[þ], signiﬁcantly
different (p , 0.000005) from the random control where
;14% of enriched NP and enriched hESC genes were
REAP[þ]. At a cutoff of ﬁve, 14% (1,368 of 9,636) of genes
that were expressed at similar levels between hESCs and NPs
were REAP[þ]. Our results suggested that a strategy of
focusing on differentially expressed genes would miss at least
14% of transcriptionally unchanged genes that may never-
theless have functional AS differences between hESCs and
NPs.
Conserved Intronic Splicing Regulatory Elements Proximal
to REAP[þ] hESC and NP Exons
Many, if not most, alternative exons undergo cell type–
speciﬁc regulation by the binding of trans-factors to splicing
regulatory cis-elements located proximal to or within the
exons. As many tissue-speciﬁc splicing cis-regulatory elements
were localized in intronic regions of AS exons, we focused on
Table 1. Significantly Enriched Gene Ontology Terms in REAP[þ] Genes (Cutoff of Two Significant ‘‘Outliers’’ per Probeset)
Gene Ontology
Identifiers
Gene Ontology
Terms
p-Value
Molecular function GO:0016455 RNA polymerase II transcription mediator activity 7.49E-04
GO:0008026 ATP-dependent helicase activity 6.88E-04
GO:0030374 Ligand-dependent nuclear receptor
transcription coactivator activity
3.63E-04
GO:0016887 ATPase activity 1.57E-04
GO:0005085 Guanyl-nucleotide exchange factor activity 8.19E-05
GO:0016874 Ligase activity 7.90E-05
GO:0046966 Thyroid hormone receptor binding* 2.43E-05
GO:0005083 Small GTPase regulatory/interacting protein activity* 1.29E-06
GO:0005488 Binding* 1.34E-07
GO:0004674 Protein serine/threonine kinase activity* 9.29E-08
GO:0004386 Helicase activity* 1.92E-08
GO:0005524 ATP binding* 3.58E-20
Biological process GO:0007049 Cell cycle 5.34E-04
GO:0030521 Androgen receptor signaling pathway 1.58E-04
GO:0006468 Protein amino acid phosphorylation 9.27E-05
GO:0000059 Protein-nucleus import, docking 6.06E-05
GO:0006890 Retrograde transport, Golgi to ER 5.22E-06
GO:0006512 Ubiquitin cycle* 2.55E-07
p-Value was computed as described in Materials and Methods. Terms with asterisks (*) were significant when compared to REAP[ ] genes in the set of REAP[þ] genes analyzed.
doi:10.1371/journal.pcbi.0030196.t001
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(ISREs) proximal to REAP[þ] exons. In addition, we wanted to
identify both common and cell type–speciﬁc ISREs. Three
sets of exons were generated: (i) REAP[þ] exons that were
predicted to be included in NPs and skipped in hESCs
(REAP[þ]
NP); (ii) REAP[þ] exons that were predicted to be
included in hESCs and skipped in NPs (REAP[þ]
hESC); and (iii)
all REAP[ ] exons. Regions of 400 base pairs ﬂanking the
exons were targeted for search. Initially, 5-mers that were
signiﬁcantly enriched between the upstream and downstream
intronic regions of REAP[þ]
NP and REAP[þ]
ES relative to
REAP[ ] exons were enumerated. We were not able to
identify 5-mers that were statistically signiﬁcantly different.
Next, we focused on splicing signals that were conserved
across mammalian genomes as a way of enhancing the signal
of detecting functional splicing regulatory sequences [66].
Exons that were orthologous across human, dog, rat, and
mouse were obtained and the ﬂanking intronic regions were
aligned (400 bases upstream and downstream separately;
Figure 9A). We enumerated k-mers that were perfectly
conserved across all four genomes in the upstream (and
downstream) intronic regions. Each conserved k-mer was
attributed a v score representing its enrichment in a set of
exons relative to another set of exons. The higher the score,
the more frequent the conserved k-mer was in the ﬁrst set
relative to the second set. As a negative control, the
associations between REAP scores and exons were shufﬂed.
The enrichment scores for all downstream intronic 5-mers
for shufﬂed REAP[þ]
NP versus set REAP[ ] exons (x-axis), and
for shufﬂed REAP[þ]
ES exons versus REAP[ ] exons (y-axis)
were displayed (Figure 9B). At a v cutoff of three, which
corresponded to a p-value of 0.0015, the majority of 5-mers
were not signiﬁcantly enriched in either shufﬂed set.
Conﬁdent that no association of k-mers with shufﬂed REAP
exons were found; we repeated the analyses for upstream and
downstream intronic 5-mers for the original unshufﬂed sets.
We identiﬁed 68 conserved 5-mers enriched upstream of
REAP[þ]
NP exons; and 34 5-mers enriched upstream of
REAP[þ]
ES exons (Figure 9C; Table S4). Of the 5-mers that
were signiﬁcantly enriched upstream of REAP[þ]
NP exons, we
identiﬁed a U-rich motif (UUUUU), a GU-rich motif
(GUGUG), and a CU-rich motif (CCUCU, CUCUC, UCUCU,
GCUCU). It is known that the heterogeneous ribonucleopro-
tein C (hnRNP C) binding site obtained by SELEX is ﬁve ‘‘U’’s
[67]. GU-rich sequences in ﬂanking intronic regions were
shown to bind to splicing factor ETR-3 to regulate AS [68].
CU-rich sequences were shown to bind the splicing factor
PTB [69]. Of the 5-mers enriched upstream of REAP[þ]
ES
exons, we observed CUAAC, which resembled the splicing
branch-signal. Of the six 5-mers that were enriched upstream
of both REAP[þ]
NP and REAP[þ]
ES exons, we identiﬁed
GCAUG, which was previously shown to be an intronic
splicing cis-element for the mammalian ﬁbronectin and
calcitonin/CGRP genes [70–72]. More recently, both mamma-
lian Fox1 and 2 have been demonstrated to regulate
alternatively spliced exons via UGCAUG binding sites in
neighboring introns in neuronal cell cultures [73].
Eighteen conserved 5-mers were signiﬁcantly enriched in
the downstream introns of REAP[þ]
ES exons; and 76 5-mers
were enriched downstream of REAP[þ]
NP exons (Table S4,
Figure 9D). We identiﬁed a motif CUCAU resembling the
Nova binding site YCAY [74], and a G-rich motif (AGGGG,
GGGGA, GGGGC, GGGGG, GGGGU) enriched in the introns
downstream of REAP[þ]
ES exons. G-rich motifs had previ-
ously been shown to be part of a bipartite signal that silences
AS exons [75]. Of the ﬁve 5-mers that were enriched
downstream of both REAP[þ]
NP and REAP[þ]
ES exons,
GCAUG and a U-rich motif (UUUUU) were identiﬁed. We
concluded that potential ISREs were enriched proximal to a
subset of REAP[þ] exons; in particular, the Fox1/2 binding site
Figure 8. Analysis of REAP[þ] Genes Relative to Transcriptional Differ-
ences
(A) Histogam of t-statistics computed from gene-level signal estimates
measuring the enrichment of genes in hESC and in NP. Genes on the
right of the vertical line at 5 were designated enriched in hESC and genes
on the left of the vertical line at  5 were designated enriched in NP;
genes in between  5 and 5 were designated as ‘‘unchanged’’ or
expressed similarly in hESC and NP.
(B) Vertical bars representing the percentage of REAP[þ] genes out of all
genes in the different classifications (dashed bar: ‘‘enriched in hESC’’;
black filled bar: ‘‘unchanged’’; white filled bar: ‘‘enriched in NP’’), at
different cutoffs of 1 to 5.
(C) Set of genes where REAP[þ] designation was randomly chosen.
Similar representation as in (B).
doi:10.1371/journal.pcbi.0030196.g008
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in hESCs and NPs.
Discussion
The ability of ESCs to generate all three embryonic germ
layers has raised the exciting possibility that hESCs may
become an unlimited source of cells for transplantation
therapies involving organs or tissues such as the liver,
pancreas, blood, and nervous system, and become tools to
explore the molecular mechanisms of human development.
Despite such interests, relatively little is understood about the
molecular mechanisms deﬁning their pluripotency and the
molecular changes important for hESCs to differentiate into
speciﬁc cell types. To understand these events, protocols are
still being developed to differentiate ESCs into a variety of
lineages.
Of particular biomedical interest is in the capacity of
hESCs to be differentiated into a self-renewing population of
NPs that can be then further coaxed into a variety of
neuronal subtypes, such as dopaminergic neurons that are
important in the treatment of Parkinson disease or chol-
inergic neurons for ALS (amyotrophic lateral sclerosis). While
many microarray studies have explored molecular differences
between hESCs and derived NPs, most, if not all, have focused
on transcriptional changes. These studies have largely
ignored intermediate RNA processing events prior to and
during translation. In recent years, AS has gained momentum
as being important in development, apoptosis, and cancer.
REAP, a regression-based method for analyzing exon array
data was introduced, and was applied to discover AS events in
Figure 9. Conserved Intronic cis-Elements Enriched Proximal to REAP[þ] Alternative Exons
(A) Schematic describing the enumeration of intronic elements across 400 bases of flanking mammalian introns (human, dog, rat, and mouse). Red and
green horizontal bars represent conserved intronic elements and nonconserved elements, respectively. Internal exons were divided into REAP[þ]
NP,
REAP[þ]
ES, and REAP[ ] exons. The v statistic was computed to represent the enrichment of conserved elements in intronic regions flanking REAP[þ]
NP
versus REAP[ ] exons (x-axis), and REAP[þ]
ES versus REAP[ ] exons (y-axis). The sign represented the direction of change, i.e., positive if enriched in
introns flanking REAP[þ] versus REAP[ ] exon. Each conserved 5-mer was associated with two numbers: the enrichment in introns proximal to REAP[þ]
NP
versus REAP[ ] exons (x-axis), and REAP[þ]
ES versus REAP[ ] exons (y-axis).
(B) Downstream intronic regions, where the association between REAP[þ] designation and the exons was shuffled.
(C) Upstream intronic regions. Circled 5-mers in the upper right quadrant represent conserved 5-mers enriched in the upstream intronic regions of
REAP[þ]
NP and REAP[þ]
ES exons.
(D) Downstream intronic regions. Circled 5-mers in the upper right quadrant represent conserved 5-mers enriched in the downstream intronic regions
of REAP[þ]
NP and REAP[þ]
ES exons.
doi:10.1371/journal.pcbi.0030196.g009
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on the assumptions that most exons in the gene of interest
and in the genome are constitutively spliced and that outliers
in a linear pairwise comparison of the signal estimates for
probesets in a gene could be detected using a robust
regression-based approach. REAP predictions were found to
correlate well with transcript-based methods for identifying
alternative exons, which interestingly suggested that current
databases of transcript information, albeit not speciﬁcally
enriched for hESC or NPs, in aggregate are nevertheless
predictive of AS events in hESC and NP. In addition, REAP[þ]
exons were also enriched for ACEScan-predicted evolutio-
narily conserved exons [55]. As ACEScan utilized a different
set of information from REAP, the agreement between both
algorithms served to further validate the predicted alter-
native exons. Additional studies in mouse ESCs and neural
derivatives will be necessary to determine if these AS events
are indeed preserved in these analogous and orthologous cell
types.
Our ﬁnding that only a minority of AS events was common
between various hESC to NP comparisons is intriguing. A
possible explanation is that the cell lines were not only
genetically different, but were also exposed to different
isolation and culture conditions. In addition, the different
differentiation protocols established as optimal for generat-
ing Nestin and Sox1 positive neural precursors may lead to
vastly different molecular changes. It is likely that post-
transcriptional changes such as AS may be more variable
despite the cells being at acknowledged ‘‘end-points’’ deﬁned
by a limited set of immunohistochemical markers. Our results
are consistent with a recent study that showed that while two
well-established hESC lines differentiate into functional
neurons, the two lines exhibited distinct differentiation
potentials, suggesting that some preprogramming had
occurred [76]. In particular, microRNA proﬁling revealed
signiﬁcant expression differences between the two hESC
lines, suggesting that microRNAs, known post-transcriptional
regulators, may sway the differentiation properties of the cell
lines [76]. We postulated that AS events may serve also to bias
the differentiation spectrum of the cells, an important avenue
for future work.
Experimental validation of REAP[þ] exons suggested a high
speciﬁcity at the expense of relatively moderate sensitivity.
We believe that the high FP rates may arise from cross-
hybridization effects that remained unaccounted for. How-
ever, our speciﬁcity of 77% at the cutoff of two signiﬁcant
outliers per probeset allowed us to estimate that at least 1,336
of 1,737 REAP[þ] exons were true AS events that changed
during neuronal differentiation of hESC cells, and/or were
different between endogeneous NPs and hESC. On average,
7% of all human exons have been estimated by transcript
data to undergo AS; thus REAP’s validation rate of 60% at the
cutoff of two is 73-fold (60/7) higher than expected. In
addition, we validated nine novel AS events that distinguish
hESCs and NPs. Consistent with our computational results,
we observed that the AS patterns in hCNS-SCns were not
always similar to those of the derived NPs. It was important to
point out that while transcriptional expression of these genes
did not distinguish these cells from one another, in several
instances the REAP-predicted AS event was able to separate
derived NPs and hCNS-SCns. A notable exception was the
alternative exon in the SLK gene, encoding a serine/threonine
kinase protein, which was commonly included in both hESCs,
i.e., the exon-excluded isoform was not present in hESCs
compared to NPs, as well as in a variety of differentiated
tissues. Closer inspection of the REAP[þ]-validated AS exon
in the SLK gene revealed strong conservation in the intronic
region ﬂanking the exon, a hallmark feature of evolutionarily
conserved AS exons [55,77,78]. A study analyzing the
expression patterns of the SLK gene suggested a potential
functional role during embryonic development and in the
adult central nervous system [79]; however, to our knowledge,
our identiﬁcation of the SLK alternative exon is the ﬁrst
report of a hESC-biased AS pattern during neuronal differ-
entiation and across a myriad of differentiated tissues. In
agreement, GO analysis suggested that genes containing
REAP[þ] exons were enriched in serine/threonine kinase
activity, of which SLK is a family member. Future work will be
required to study the impact of AS in these genes in hESCs
and NPs. We predict it is unlikely that the alternative exon in
the SLK gene is the only case common across hESC and
different from differentiated tissues, but further studies will
be necessary to identify other hESC-speciﬁc exons.
REAP[þ] exons were underrepresented in genes that were
differentially transcriptionally regulated in hESCs and NPs.
Our results act as a reminder that focusing only on genes that
are differentially expressed will overlook RNA processing
events that may be biologically relevant to the system of
interest. Finally, we identiﬁed potential cis-regulatory in-
tronic elements conserved and enriched proximal to the
REAP[þ] exons. In particular, the FOX1/2 binding site,
GCUAG, was conserved and enriched in the ﬂanking introns
of a subset of REAP[þ] exons. Further studies will be required
to explore the importance of FOX1 family members in early
neuronal differentiation.
In conclusion, our introduction of REAP and its applica-
tion to identifying AS events has revealed new and
unanticipated insights into hESC biology and their transition
to NP cells. Collectively, these exons represent a set of
molecular changes that are likely to be important for
studying human neural differentiation with applications in
neuronal regenerative medicine.
Materials and Methods
Maintenance and differentiation of hESCs and hCNS-SCns. hESC
line Cy203 (Cythera) was cultured as previously described [12]. To
differentiate into neuroepithelial precursor cells, colonies were
manually isolated from mouse embryonic ﬁbroblasts (MEFs) and cut
in small pieces. These pieces were transferred to a T75 ﬂask with
hESCs differentiation media (same hESC medium but 10% KSR and
no FGF-2). Medium was changed the next day by transferring the
ﬂoating hESC aggregates to a new ﬂask. After culturing for a week,
the hESC cell aggregates formed mature embroid bodies (EBs; ;10
um round clusters with dark centers). EBs were plated on a coated 10-
cm dish in hESC differentiation media. The next day, the medium was
changed to DMEM/F12 supplemented with ITS and ﬁbronectin.
Medium was changed every other day for a week or until the cells
formed rosette-like columnar structures that were isolated manually.
These structures were then transferred to coated dishes in neural
induction medium (DMEM/F12 supplemented with N2 and FGF-2) for
a week. Elongated single cells were separated from leftover aggregates
using non-enzymatic dissociation. After one to two passages, the cells
formed a monolayer of homogeneous NPs (negative for Sox1
immunostaining). Upon conﬂuence, cells will form neurospheres
that can also be isolated from the neuroepithelial precursor cells
(positive for Sox1 immunostaining). At any of these two stages, pan-
neuronal differentiation can be achieved after three to four weeks.
hESC line HUES6 was cultured on MEF feeders as previously
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matrigel coated plates. Cells grown on matrigel were grown in
MEF-conditioned medium and FGF-2 was used at 20 ng/mL instead of
10 ng/mL for cells grown on MEFs. To differentiate neuroepithelial
precursors, colonies were removed by treatment with collagenase IV
(Sigma) and washed three times in growth media. The pieces of
colonies were resuspended in HUES growth media without FGF2 in
an uncoated bacterial Petri dish to form EBs. After one week, EBs
were plated on polyornathine/laminin coated plates in DMEM/F12
supplemented with N2 and FGF2. Rosette structures were manually
collected and enzymatically dissociated with TryPLE (Invitrogen),
plated on polyornathine/laminin coated plates, and grown in DMEM/
F12 supplemented with N2 and B27-RA and 20 ng/mL FGF-2. Cells
could be grown as a monolayer for up to at least ten passages. Cells
were Sox1 and nestin positive and readily differentiated into neurons
upon withdrawal of FGF-2. Human central nervous system stem cell
line FBR1664 (StemCells) which is referred to as hCNS-SCns in the
main text was cultured as previously described [23]. The cells were
cultured in medium consisting of Ex Vivo 15 (BioWhittaker) medium
with N2 supplement (GIBCO), FGF2 (20 ng/mL), epidermal growth
factor (20 ng/mL), lymphocyte inhibitory factor (10 ng/mL), 0.2 mg/ml
heparin, and 60 ug/mL N-acetylcysteine. Cultures were fed weekly and
passaged at ;two to three weeks using collagenases (Roche). The
following antibodies and corresponding dilutions were utilized for
the immunohistochemical analysis of marker genes in Cyt-ES and
HUES6-ES: Sox2 (Chemicon, 1:500), Oct4 (Santa Cruz, 1:500), Sox1
(Chemicon, 1:500), Nestin (Pharmingen, 1:250); hCNS-SCns: Sox2
(Chemicon, 1:200), Nestin (Chemicon, 1:200).
RNA preparation and array hybridization. Total RNA from cells
was processed as follows. Cells were lysed in 1 mL of RNA-bee
(Teltest). The RNA was isolated by chloroform extraction of the
aqueous phase, followed by isopropanol precipitation as per the
manufacturer’s instructions. The precipitated RNA was washed in
75% ethanol and eluted with DEPC-treated water. Five ug of RNA was
treated with RQ1 DNAase (Promega) according to the manufacturer’s
instructions. One ug of total RNA for each sample was processed
using the Affymetrix GeneChip Whole Transcript Sense Target
Labeling Assay (Affymetrix). Ribosomal RNA was reduced with the
RiboMinus Kit (Invitrogen). Target material was prepared using
commercially available Affymetrix GeneChip WT cDNA Synthesis
Kit, WT cDNA Ampliﬁcation Kit, and WT Terminal Labeling Kit
(Affymetrix) as per manufacturer’s instructions. Hybridization cock-
tails containing ;5 ug of fragmented and labeled DNA target were
prepared and applied to GeneChip Human Exon 1.0 ST arrays.
Hybridization was performed for 16 hours using the Fluidics 450
station. Arrays were scanned using the Affymetrix 3000 7G scanner
and GeneChip Operating Software version 1.4 to produce .CEL
intensity ﬁles.
Detection of AS by RT-PCR. cDNAs were generated from total
RNA with Superscript III reverse transcriptase (Invitrogen). PCR
reactions were performed with primer pairs designed for AS targets
(annealing at 58 8C and ampliﬁcation for 30 or 35 cycles). PCR
products were resolved on either 1.5% or 3% agarose gel in TBE. The
Ethidium Bromide-stained gels were scanned with Typhoon 8600
scanner (Molecular Dynamics) for quantiﬁcation. The number of true
positives (TP; false negatives, FN) was computed as the number of
REAP[þ] (REAP[ ]) exons that were validated by RT-PCR as AS. The
number of true negatives (TN; or FPs) was computed as the number
of REAP[ ] (REAP[þ]) exons that were validated by RT-PCR as
constitutively spliced. The true (false) positive rate was computed as
TP (FP) divided by the total number of REAP[þ] exons in the
experimentally validated set. The true (false) negative rate was
computed as the TN (FN) divided by the total number of REAP[ ]
exons in the experimentally validated set. Sensitivity was computed as
TP/(TPþFN) and speciﬁcity was computed as TN/(FPþTN).
Sequence databases. Genome sequences of human (hg17), dog
(canFam1), rat (rn3), and mouse (mm5) were obtained from UCSC, as
were the whole-genome MULTIZ alignments [80]. The lists of known
human genes (knownGene containing 43,401 entries) and known
isoforms (knownIsoforms containing 43,286 entries in 21,397 unique
isoform clusters) with annotated exon alignments to human hg17
genomic sequence were processed as follows. Known genes that were
mapped to different isoform clusters were discarded. All mRNAs
aligned to hg17 that were greater than 300 bases long were clustered
together with the known isoforms. Genes containing less than three
exons were removed from further consideration. A total of 2.7
million spliced ESTs were mapped onto the 17,478 high-quality genes
to infer AS. Exons with canonical splice signals (GT-AG, AT-AC, GC-
AG) were retained, resulting in a total of 213,736 exons. Of these,
197,262 (92% of all exons) were constitutive exons, 13,934 exons (7%)
had evidence of exon-skipping, 1,615 (1%) exons were mutually
exclusive alternative events, 5,930 (3%) exons had alternative 39 splice
sites, 5,181 (2%) exons had alternative 59 splice sites, and 175 (,1%)
exons overlapped another exon, but did not fall into the above
classiﬁcations. A total of 324,139 probesets from the Affymetrix
Human Exon 1.0 ST array were mapped to 208,422 human exons,
representing 17,431 genes. These probesets were used to derive gene
and exon-level signal estimates from the CEL ﬁles. The four-way
mammalian (four-mammal) whole-genome alignment (hg17, can-
Fam1, mm5, rn3) was extracted from the eight-way vertebrate
MULTIZ alignments (hg17, panTrol1, mm5, rn3, canFam1, galGal2,
fr1, danRer1) obtained from the UCSC Genome Browser. Four-way
mammal alignments were extracted for all internal exons, and 400
bases of ﬂanking intronic sequence, resulting in a total of 161,731
conserved internal exons. A total of 145,613 (90% of total) conserved
internal exons were constitutive exons, 13,653 exons (8%) had
evidence of exon-skipping, 1,576 exons were mutually exclusive
alternative events, 5,818 exons had alternative 39 splice sites, 5,046
exons had alternative 59 splice sites, and 168 exons overlapped
another exon.
Exon array analysis. The Affymetrix Power Tools (APT) suite of
programs was obtained from http://www.affymetrix.com/support/
developer/powertools/index.affx. Exon (probeset) and gene-level
signal estimates were derived from the CEL ﬁles by RMA–sketch
normalization as a method in the apt-probeset-summarize program.
To determine if the signal intensity for a given probeset is above the
expected level of background noise, we utilized the DABG (detection
above background) quantiﬁcation method available in the apt-
probeset-summarize program as part of Affymetrix Power Tools
(APT). Brieﬂy, DABG compared the signal for each probe to a
background distribution of signals from anti-genomic probes with
the same GC content. The DABG algorithm generated a p-value
representing the probability that the signal intensity of a given probe
was part of the background distribution. We considered a probeset
with a DABG p-value lower than 0.05 as detected above background.
The statistic thCNS-SCns,ESC ¼ (lhCNS-SCns   lESC) / sqrt (((nhCNS-SCns  
1)r
2
hCNS-SCns þ (nESC   1)r
2
ESC)(nhCNS-SCns þ nESC)) / ((nhCNS-SCnsnESC)
(nhCNS-SCns þ nESC   2))), where nhCNS-SCns and nESC were the number
of replicates, lhCNS-SCns and lESC were the mean, and r
2
hCNS-SCns and
r
2
ESC were the variances of the expression values for the two datasets
used to represent the differential enrichment of a gene using gene-
level estimates in hCNS-SCns relative to hESCs. Multiple hypothesis
testing was corrected by controlling for the false discovery rate
(Benjamini-Hochberg).
AS detection by REAP. The log2 signal estimate xij for probeset i in
cell-type j had to satisfy two conditions, otherwise the probeset was
discarded: (i) 2 , xij , 10,000 for all conditions/cell-types j; and (ii)
DABG p-value , 0.05 for all replicates in at least one condition/cell-
type j. A gene had to have ﬁve probesets that satisﬁed the two
conditions above in order to be considered for robust regression
analysis. After generating the points (as described in the Results
section), we utilized the robust regression method rlm in R-package
‘‘MASS’’ (version 6.1–2) with M-estimation and a maximum iteration
setting of 30 to estimate the linear function yi ¼ axi þ b. For each
probeset, we computed the error term ei,, which was the difference
between the actual value yi and the estimated value ni, from the
estimated function ni ¼ Axi þ B, where A and B were estimates of a
and b. The error term variance was estimated by se
2 ¼ Rei
2/(n   p),
which was used to estimate the variance of the predicted value, sni
2 ¼
se
2(n
 1 þ (xi   lx)
2 /s x
2(n   1)). Here, n referred to the number of
points (generated for each gene), and p referred to the number of
independent variables (p¼2 in our method); and lx¼Rxi
2/n; sx
2¼n
 1
R(xi   lx)
2. Following Belsley et al. [81], we deﬁned the leverage hi of
the i
th point as hi ¼ n
 1 þ (xi   lx)
2 /s x
2(n   1). Here we considered a
point to have high leverage if hi . 3p/n. Next, we calculated the
covariance ratio, covi ¼ (si
2/sr
2)
p/(1   hi), which is the ratio of the
determinant of the covariance matrix after deleting the i
th
observation to the determinant of the covariance matrix with the
entire sample. We considered a point to have high inﬂuence if jcovi 
1j . 3p/n. Lastly, we computed the studentized residuals, rstudenti ¼
ei /( s (i)
2 (1  hi)
0.5), where s(i)
2 ¼(n-p)se
2 / (n-p-1) – ei
2 / (n-p-1)(1 hi),
the error term variance after deleting the i
th point. As rstudenti was
distributed as Student’s t-distribution with n-p-1 degrees of freedom,
each rstudenti value was associated with a p-value. We considered a
point to be an ‘‘outlier’’ if p , 0.01.
Identiﬁcation of motifs. The enrichment score of a sequence
element of length k (k-mer) in one set of sequences (set 1) versus
another set of sequences (set 2) was represented by the non-
parametric v
2 statistic with Yates correction, computed from the
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element in set 1; T12: number of occurrences of all other elements of
similar length in set 1; T21: number of occurrences of element in set 2;
T22: number of occurrences of all other elements of similar length in
set 2. All elements had to be greater than 5. To correct for multiple
hypothesis testing, p-values were multiplied by the total number of
comparisons.
Supporting Information
Figure S1. Number of Overlapping and Non-Overlapping Transcrip-
tionally Enriched Genes in NP and hESC between Pairwise Gene-
Level Comparisons of Different hESC to NP Samples Displayed as
Venn Diagrams
For each hESC to NP pair, the percentage of enriched genes found in
the intersection was indicated in parentheses.
Found at doi:10.1371/journal.pcbi.0030196.sg001 (174 KB PDF).
Table S1. Number of Probesets with Signiﬁcant ‘‘Outliers’’
Found at doi:10.1371/journal.pcbi.0030196.st001 (39 KB DOC).
Table S2. REAP[þ] Exons Were Deﬁned as Probesets Matching
Internal Exons with at Least Two (or Three) Signiﬁcant Points
‘‘1’’ in the table indicated that the event had to be present in the
comparisons above (Cyt-ES versus hCNS-SCns; HUES6-ES versus
hCNS-SCns; Cyt-NP versus Cyt-ES; HUES6-NP versus HUES6-ES).
Found at doi:10.1371/journal.pcbi.0030196.st002 (44 KB DOC).
Table S3. Experimental Validation of REAP[þ] Targets
‘‘N’’ and ‘‘P’’ indicated negative or positive validation by RT-PCR.
The genomic coordinates of the exon for hg17 were represented as
chromosome, followed by start and end, separated by ‘‘:’’. ‘‘1’’ and
‘‘ 1’’ indicated whether the exon was REAP[þ] ‘‘1’’ or REAP[ ] ‘‘ 1’’,
at the different cutoffs of one to four.
Found at doi:10.1371/journal.pcbi.0030196.st003 (130 KB DOC).
Table S4. Conserved 5-mers Enriched in Downstream/Upstream
Intronic Regions of REAP[þ] Exons Included in ES (NP) and Skipped
in NP (ES)
For example, in row 6 ACCTG was enriched in the downstream
intronic regions of exons included in ES and skipped in NP, relative
to REAP[ ] exons.
Found at doi:10.1371/journal.pcbi.0030196.st004 (34 KB DOC).
Acknowledgments
We thank StemCells for generous donation of the hCNS-SCns line,
and CyThera for generous donation of the CyThera hESC line. We
thank Mary Lynn Gage for helpful comments on the manuscript.
Author contributions. GWY and XX conceived and designed the
experiments. GWY designed and wrote the algorithm. GWY, XX,
TYL, and ARM performed the experiments. GWY and XX analyzed
the data. GWY, CTC, NGC, and FHG contributed reagents/materials/
analysis tools. GWY wrote the paper.
Funding. GWY is a Junior Fellow at the Crick-Jacobs Center for
Theoretical and Computational Biology at the Salk Institute. ARM is
a Rett Syndrome Research Foundation (RSRF) Fellow. CTC was
supported by the California Institute for Regenerative Medicine.
FHG was supported by the Lookout Fund, the Christopher Reeves
Paralysis Foundation, and the Michael J. Fox Foundation. This work
was supported by a grant from the California Institute for
Regenerative Medicine.
Competing interests. The authors have declared that no competing
interests exist.
References
1. Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, et al. (2005)
Somatic mosaicism in neuronal precursor cells mediated by L1 retro-
transposition. Nature 435: 903–910.
2. Muotri AR, Gage FH (2006) Generation of neuronal variability and
complexity. Nature 441: 1087–1093.
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al.
(1998) Embryonic stem cell lines derived from human blastocysts. Science
282: 1145–1147.
4. Keller G (2005) Embryonic stem cell differentiation: emergence of a new
era in biology and medicine. Genes Dev 19: 1129–1155.
5. Sonntag KC, Simantov R, Isacson O (2005) Stem cells may reshape the
prospect of Parkinson’s disease therapy. Brain Res Mol Brain Res 134: 34–
51.
6. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, et al. (2001)
Neural progenitors from human embryonic stem cells. Nat Biotechnol 19:
1134–1140.
7. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, et al. (2001)
Enrichment of neurons and neural precursors from human embryonic
stem cells. Exp Neurol 172: 383–397.
8. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, et al. (2004) Derivation
of midbrain dopamine neurons from human embryonic stem cells. Proc
Natl Acad Sci U S A 101: 12543–12548.
9. Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, et al. (2005)
Speciﬁcation of motoneurons from human embryonic stem cells. Nat
Biotechnol 23: 215–221.
10. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, et al. (2005) Directed
differentiation of dopaminergic neuronal subtypes from human embryonic
stem cells. Stem Cells 23: 781–790.
11. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS (2005)
Human embryonic stem cells differentiate into oligodendrocytes in high
purity and myelinate after spinal cord transplantation. Glia 49: 385–396.
12. Muotri AR, Nakashima K, Toni N, Sandler VM, Gage FH (2005) Develop-
ment of functional human embryonic stem cell-derived neurons in mouse
brain. Proc Natl Acad Sci U S A 102: 18644–18648.
13. Cai J, Chen J, Liu Y, Miura T, Luo Y, et al. (2006) Assessing self-renewal and
differentiation in human embryonic stem cell lines. Stem Cells 24: 516–530.
14. Bhattacharya B, Cai J, Luo Y, Miura T, Mejido J, et al. (2005) Comparison of
the gene expression proﬁle of undifferentiated human embryonic stem cell
lines and differentiating embryoid bodies. BMC Dev Biol 5: 22.
15. Miura T, Luo Y, Khrebtukova I, Brandenberger R, Zhou D, et al. (2004)
Monitoring early differentiation events in human embryonic stem cells by
massively parallel signature sequencing and expressed sequence tag scan.
Stem Cells Dev 13: 694–715.
16. Brandenberger R, Wei H, Zhang S, Lei S, Murage J, et al. (2004)
Transcriptome characterization elucidates signaling networks that control
human ES cell growth and differentiation. Nat Biotechnol 22: 707–716.
17. Brandenberger R, Khrebtukova I, Thies RS, Miura T, Jingli C, et al. (2004)
MPSS proﬁling of human embryonic stem cells. BMC Dev Biol 4: 10.
18. Gage FH, Ray J, Fisher LJ (1995) Isolation, characterization, and use of stem
cells from the CNS. Annu Rev Neurosci 18: 159–192.
19. Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, et al. (1996) Multipotent
CNS stem cells are present in the adult mammalian spinal cord and
ventricular neuroaxis. J Neurosci 16: 7599–7609.
20. Weissman IL (2000) Stem cells: units of development, units of regeneration,
and units in evolution. Cell 100: 157–168.
21. Taylor H, Minger SL (2005) Regenerative medicine in Parkinson’s disease:
generation of mesencephalic dopaminergic cells from embryonic stem
cells. Curr Opin Biotechnol 16: 487–492.
22. Hermann A, Gerlach M, Schwarz J, Storch A (2004) Neurorestoration in
Parkinson’s disease by cell replacement and endogenous regeneration.
Expert Opin Biol Ther 4: 131–143.
23. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct
isolation of human central nervous system stem cells. Proc Natl Acad Sci U
S A 97: 14720–14725.
24. Wright LS, Li J, Caldwell MA, Wallace K, Johnson JA, et al. (2003) Gene
expression in human neural stem cells: effects of leukemia inhibitory
factor. J Neurochem 86: 179–195.
25. Storch A, Paul G, Csete M, Boehm BO, Carvey PM, et al. (2001) Long-term
proliferation and dopaminergic differentiation of human mesencephalic
neural precursor cells. Exp Neurol 170: 317–325.
26. Arsenijevic Y, Villemure JG, Brunet JF, Bloch JJ, Deglon N, et al. (2001)
Isolation of multipotent neural precursors residing in the cortex of the
adult human brain. Exp Neurol 170: 48–62.
27. Cai J, Shin S, Wright L, Liu Y, Zhou D, et al. (2006) Massively parallel
signature sequencing proﬁling of fetal human neural precursor cells. Stem
Cells Dev 15: 232–244.
28. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G Jr, et al.
(2003) Identiﬁcation and isolation of multipotential neural progenitor cells
from the subcortical white matter of the adult human brain. Nat Med 9:
439–447.
29. Moe MC, Westerlund U, Varghese M, Berg-Johnsen J, Svensson M, et al.
(2005) Development of neuronal networks from single stem cells harvested
from the adult human brain. Neurosurgery 56: 1182–1188; discussion 1188–
1190.
30. Kukekov VG, Laywell ED, Suslov O, Davies K, Schefﬂer B, et al. (1999)
Multipotent stem/progenitor cells with similar properties arise from two
neurogenic regions of adult human brain. Exp Neurol 156: 333–344.
31. Kirschenbaum B, Nedergaard M, Preuss A, Barami K, Fraser RA, et al.
(1994) In vitro neuronal production and differentiation by precursor cells
derived from the adult human forebrain. Cereb Cortex 4: 576–589.
PLoS Computational Biology | www.ploscompbiol.org October 2007 | Volume 3 | Issue 10 | e196 1966
Alternative Splicing in Human ES and Progenitor Cells32. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, et al. (1999)
Identiﬁcation of a neural stem cell in the adult mammalian central nervous
system. Cell 96: 25–34.
33. Hermann A, Maisel M, Liebau S, Gerlach M, Kleger A, et al. (2006)
Mesodermal cell types induce neurogenesis from adult human hippo-
campal progenitor cells. J Neurochem 98: 629–640.
34. Westerlund U, Moe MC, Varghese M, Berg-Johnsen J, Ohlsson M, et al.
(2003) Stem cells from the adult human brain develop into functional
neurons in culture. Exp Cell Res 289: 378–383.
35. Maisel M, Herr A, Milosevic J, Hermann A, Habisch HJ, et al. (2007)
Transcription proﬁling of adult and fetal human neuroprogenitors
identiﬁes divergent paths to maintain the neuroprogenitor cell state. Stem
Cells 25: 224–234.
36. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing.
Annu Rev Biochem 72: 291–336.
37. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and
understanding nonsense: exonic mutations that affect splicing. Nat Rev
Genet 3: 285–298.
38. Graveley BR (2001) Alternative splicing: increasing diversity in the
proteomic world. Trends Genet 17: 100–107.
39. Zavolan M, Kondo S, Schonbach C, Adachi J, Hume DA, et al. (2003) Impact
of alternative initiation, splicing, and termination on the diversity of the
mRNA transcripts encoded by the mouse transcriptome. Genome Res 13:
1290–1300.
40. Blencowe BJ (2006) Alternative splicing: new insights from global analyses.
Cell 126: 37–47.
41. Black DL, Grabowski PJ (2003) Alternative pre-mRNA splicing and
neuronal function. Prog Mol Subcell Biol 31: 187–216.
42. Grabowski PJ, Black DL (2001) Alternative RNA splicing in the nervous
system. Prog Neurobiol 65: 289–308.
43. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, et al. (2003) CLIP identiﬁes
Nova-regulated RNA networks in the brain. Science 302: 1212–1215.
44. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, et al. (2000)
Nova-1 regulates neuron-speciﬁc alternative splicing and is essential for
neuronal viability. Neuron 25: 359–371.
45. Rahman L, Bliskovski V, Reinhold W, Zajac-Kaye M (2002) Alternative
splicing of brain-speciﬁc PTB deﬁnes a tissue-speciﬁc isoform pattern that
predicts distinct functional roles. Genomics 80: 245–249.
46. Ashiya M, Grabowski PJ (1997) A neuron-speciﬁc splicing switch mediated
by an array of pre-mRNA repressor sites: evidence of a regulatory role for
the polypyrimidine tract binding protein and a brain-speciﬁc PTB
counterpart. Rna 3: 996–1015.
47. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, et al. (2007) A post-
transcriptional regulatory switch in polypyrimidine tract-binding proteins
reprograms alternative splicing in developing neurons. Genes Dev 21:
1636–1652.
48. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single
base-pair substitutions in mRNA splice junctions of human genes: causes
and consequences. Hum Genet 90: 41–54.
49. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease.
Genes Dev 17: 419–437.
50. Yeo G, Holste D, Kreiman G, Burge CB (2004) Variation in alternative
splicing across human tissues. Genome Biol 5: R74.
51. Xu Q, Modrek B, Lee C (2002) Genome-wide detection of tissue-speciﬁc
alternative splicing in the human transcriptome. Nucleic Acids Res 30:
3754–3766.
52. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. (2003)
Genome-wide survey of human alternative pre-mRNA splicing with exon
junction microarrays. Science 302: 2141–2144.
53. Pritsker M, Doniger TT, Kramer LC, Westcot SE, Lemischka IR (2005)
Diversiﬁcation of stem cell molecular repertoire by alternative splicing.
Proc Natl Acad Sci U S A 102: 14290–14295.
54. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RA, et al. (2004)
Unique gene expression signatures of independently-derived human
embryonic stem cell lines. Hum Mol Genet 13: 601–608.
55. Yeo GW, Van Nostrand E, Holste D, Poggio T, Burge CB (2005)
Identiﬁcation and analysis of alternative splicing events conserved in
human and mouse. Proc Natl Acad Sci U S A 102: 2850–2855.
56. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, et al. (2004)
Derivation of embryonic stem-cell lines from human blastocysts. N Engl J
Med 350: 1353–1356.
57. Lowell S, Benchoua A, Heavey B, Smith AG (2006) Notch promotes neural
lineage entry by pluripotent embryonic stem cells. PLoS Biol 4: e121.
doi:10.1371/journal.pbio.0040121
58. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, et
al. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo.
Nature 442: 823–826.
59. Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, et al. (2005) DNER acts
as a neuron-speciﬁc Notch ligand during Bergmann glial development. Nat
Neurosci 8: 873–880.
60. Pevny LH, Sockanathan S, Placzek M, Lovell-Badge R (1998) A role for
SOX1 in neural determination. Development 125: 1967–1978.
61. Baldassarre G, Romano A, Armenante F, Rambaldi M, Paoletti I, et al.
(1997) Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in
testis germ cell tumors and its effects on growth and differentiation of
embryonal carcinoma cell line NTERA2/D1. Oncogene 15: 927–936.
62. Xu C, Liguori G, Adamson ED, Persico MG (1998) Speciﬁc arrest of
cardiogenesis in cultured embryonic stem cells lacking Cripto-1. Dev Biol
196: 237–247.
63. Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of
mammalian development. Stem Cells 19: 271–278.
64. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, et al. (2003) The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell 113: 631–642.
65. Zhang JZ, Gao W, Yang HB, Zhang B, Zhu ZY, et al. (2006) Screening for
genes essential for mouse embryonic stem cell self-renewal using a
subtractive RNA interference library. Stem Cells 24: 2661–2668.
66. Yeo GW, Nostrand EL, Liang TY (2007) Discovery and analysis of
evolutionarily conserved intronic splicing regulatory elements. PLoS Genet
3: e85. doi:10.1371/journal.pgen.0030085
67. Gorlach M, Burd CG, Dreyfuss G (1994) The determinants of RNA-binding
speciﬁcity of the heterogeneous nuclear ribonucleoprotein C proteins. J
Biol Chem 269: 23074–23078.
68. Faustino NA, Cooper TA (2005) Identiﬁcation of putative new splicing
targets for ETR-3 using sequences identiﬁed by systematic evolution of
ligands by exponential enrichment. Mol Cell Biol 25: 879–887.
69. Chan RC, Black DL (1997) Conserved intron elements repress splicing of a
neuron-speciﬁc c-src exon in vitro. Mol Cell Biol 17: 2970.
70. Huh GS, Hynes RO (1994) Regulation of alternative pre-mRNA splicing by
a novel repeated hexanucleotide element. Genes Dev 8: 1561–1574.
71. Hedjran F, Yeakley JM, Huh GS, Hynes RO, Rosenfeld MG (1997) Control of
alternative pre-mRNA splicing by distributed pentameric repeats. Proc
Natl Acad Sci U S A 94: 12343–12347.
72. Lim LP, Sharp PA (1998) Alternative splicing of the ﬁbronectin EIIIB exon
depends on speciﬁc TGCATG repeats. Mol Cell Biol 18: 3900–3906.
73. Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL (2005)
Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal
splicing regulators in mammals. Mol Cell Biol 25: 10005–10016.
74. Dredge BK, Darnell RB (2003) Nova regulates GABA(A) receptor gamma2
alternative splicing via a distal downstream UCAU-rich intronic splicing
enhancer. Mol Cell Biol 23: 4687–4700.
75. Han K, Yeo G, An P, Burge CB, Grabowski PJ (2005) A combinatorial code
for splicing silencing: UAGG and GGGG motifs. PLoS Biol 3: e158. doi:10.
1371/journal.pbio.0030158
76. Wu H, Xu J, Pang ZP, Ge W, Kim KJ, et al. (2007) Integrative genomic and
functional analyses reveal neuronal subtype differentiation bias in human
embyronic stem cell lines. Proc Natl Acad Sci U S A 104: 13821–13826.
77. Sugnet CW, Kent WJ, Ares M Jr, Haussler D (2004) Transcriptome and
genome conservation of alternative splicing events in humans and mice.
Pac Symp Biocomput 2004: 66–77.
78. Sorek R, Ast G (2003) Intronic sequences ﬂanking alternatively spliced
exons are conserved between human and mouse. Genome Res 13: 1631–
1637.
79. Zhang YH, Hume K, Cadonic R, Thompson C, Hakim A, et al. (2002)
Expression of the Ste20-like kinase SLK during embryonic development
and in the murine adult central nervous system. Brain Res Dev Brain Res
139: 205–215.
80. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, et al. (2003)
The UCSC Genome Browser Database. Nucleic Acids Res 31: 51–54.
81. Belsley DA, Kuh E, Welsch RE (1980) Regression diagnostics: identifying
inﬂuential data and sources of collinearity. New York: John Wiley and Sons.
PLoS Computational Biology | www.ploscompbiol.org October 2007 | Volume 3 | Issue 10 | e196 1967
Alternative Splicing in Human ES and Progenitor Cells